Indeed, the updated American Association for the Study of Liver Diseases (AASLD) guidelines currently exclude AFP from surveillance testing and use ultrasonography as the optimal option for the detection of early HCC [10]. The gene discussed is AFP; the disease is hepatocellular carcinoma.